1. Home
  2. GLU vs ONCY Comparison

GLU vs ONCY Comparison

Compare GLU & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gabelli Global Utility of Beneficial Ownership

GLU

Gabelli Global Utility of Beneficial Ownership

HOLD

Current Price

$19.98

Market Cap

116.8M

Sector

Finance

ML Signal

HOLD

Logo Oncolytics Biotech Inc.

ONCY

Oncolytics Biotech Inc.

HOLD

Current Price

$0.97

Market Cap

106.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GLU
ONCY
Founded
2004
1998
Country
United States
Canada
Employees
N/A
N/A
Industry
Finance/Investors Services
Pharmaceuticals and Biotechnology
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
116.8M
106.1M
IPO Year
N/A
1999

Fundamental Metrics

Financial Performance
Metric
GLU
ONCY
Price
$19.98
$0.97
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$6.00
AVG Volume (30 Days)
12.4K
655.2K
Earning Date
01-01-0001
11-12-2025
Dividend Yield
8.60%
N/A
EPS Growth
N/A
N/A
EPS
0.62
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$22.50
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.61
$0.33
52 Week High
$15.40
$1.51

Technical Indicators

Market Signals
Indicator
GLU
ONCY
Relative Strength Index (RSI) 82.95 46.05
Support Level $18.36 $0.94
Resistance Level $18.65 $1.06
Average True Range (ATR) 0.24 0.06
MACD 0.13 0.00
Stochastic Oscillator 99.41 35.67

Price Performance

Historical Comparison
GLU
ONCY

About GLU Gabelli Global Utility of Beneficial Ownership

Gabelli Global Utility & Income Trust is a non-diversified, closed-end management investment company. The Fund's objective is to seek a consistent level of after-tax total return. It predominantly invests in stocks of companies involved to a substantial extent in providing products, services, or equipment for the generation or distribution of electricity, gas, or water and infrastructure operations, and in equity securities including preferred securities of companies in other industries, in each case in such securities that are expected to pay periodic dividends.

About ONCY Oncolytics Biotech Inc.

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.

Share on Social Networks: